These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7636524)

  • 41. Isopycnic density-gradient centrifugation: a separation parameter which improves flow cytometric measurements on heterogeneous tumors.
    Sonka J; Stöhr M; Vogt-Schaden M; Volm M
    Cytometry; 1983 Sep; 4(2):141-9. PubMed ID: 6628136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphocyte subset analysis for the diagnosis of rejection and infection in recipients of liver transplants.
    Jindal RM; Greer G; Popescu I; Sidner RA
    Am Surg; 1999 Jan; 65(1):77-80. PubMed ID: 9915538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells.
    Nagasawa H; Li CY; Maki CG; Imrich AC; Little JB
    Cancer Res; 1995 May; 55(9):1842-6. PubMed ID: 7728750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Flow cytometric analysis, mechanism of action and evaluation of viability by antineoplastic agents].
    Kawamoto K
    Nihon Rinsho; 1992 Oct; 50(10):2360-7. PubMed ID: 1447805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can pathology predict response role of classic methods and modern techniques.
    Mostofi FK; Sesterhenn IA; Davis CJ
    Prog Clin Biol Res; 1991; 370():237-48. PubMed ID: 1924455
    [No Abstract]   [Full Text] [Related]  

  • 47. [Physical considerations on the method for improving the outcome of radiation therapy].
    Onai Y
    Gan No Rinsho; 1990 Oct; 36(13):2369-72. PubMed ID: 2250359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of cell cycle analysis by flow cytometry in gynecology and obstetrics].
    Gabriele M; Barrière P; Sagot P; Robillard N; Samake M; Lopes P
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(4):463-9. PubMed ID: 2674269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The Will Roger's phenomenon--fact or fiction?].
    Hermanek P
    Chirurg; 1996 Aug; 67(8):769-70. PubMed ID: 8964148
    [No Abstract]   [Full Text] [Related]  

  • 50. Statistical case puzzle. The case of the despondent student.
    Strayhorn JM
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):466-7. PubMed ID: 8444780
    [No Abstract]   [Full Text] [Related]  

  • 51. Comment on: Tumor volume as a response predictor in radiotherapy.
    Nieder C
    Radiother Oncol; 1998 Sep; 48(3):347-8. PubMed ID: 9925259
    [No Abstract]   [Full Text] [Related]  

  • 52. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Labelling indices in human tumours: to apply corrections or not--that is the question.
    Bergström C; Begg A; Palmqvist R; Waites A; Denekamp J
    Br J Cancer; 1999 Jul; 80(10):1635-43. PubMed ID: 10408411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Origins of ... flow cytometry and applications in oncology.
    Giaretti W
    J Clin Pathol; 1997 Apr; 50(4):275-7. PubMed ID: 9215140
    [No Abstract]   [Full Text] [Related]  

  • 55. The predictive value of tumor-cell kinetic parameters in radiotherapy: considerations regarding data production and analysis.
    Terry NH; Peters LJ
    J Clin Oncol; 1995 Aug; 13(8):1833-6. PubMed ID: 7636524
    [No Abstract]   [Full Text] [Related]  

  • 56. The predictive role of flow cytometry-derived tumor potential doubling time (Tpot) in radiotherapy: open questions and future perspectives.
    Antognoni P; Terry NHA ; Richetti A; Luraghi R; Tordiglione M; Danova M
    Int J Oncol; 1998 Feb; 12(2):245-56. PubMed ID: 9458346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Measurement of DNA content and analysis of chromosome using flow cytometry].
    Akagi K; Uda M; Itagaki Y; Tanaka Y
    Gan No Rinsho; 1989 Oct; 35(13):1559-65. PubMed ID: 2531240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical value of the potential doubling time (Tpot) measured by flow cytometry].
    Dubray B; Maciorowsky Z; Cosset JM; Terry NH
    Bull Cancer; 1995; 82(5):331-8. PubMed ID: 7626840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic versus predictive flow cytometry.
    Valet G
    Lab Hematol; 2004; 10(3):166-8. PubMed ID: 15529434
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.